MID-REGIONAL PROADRENOMEDULLIN (MR-PROADM) AS A BIOMARKER IN PATIENTS WITH CHRONIC KIDNEY DISEASE AND HYPERTENSION - STUDY CONTINUATION

被引：0
|
作者：
Czajkowska, Katarzyna [1 ]
Zbroch, Edyta [2 ]
Bielach-Bazyluk, Angelika [1 ]
Koc-Zorawska, Ewa [1 ]
Kakareko, Katarzyna [1 ]
Rydzewska-Rosolowska, Alicja [1 ]
Hryszko, Tomasz [1 ]
机构：
[1] Med Univ, Dialysis Unit, Dept Nephrol & Hypertens 2, Bialystok, Poland
[2] Med Univ, Dept Internal Med & Hypertens, Bialystok, Poland
来源：
JOURNAL OF HYPERTENSION | 2022年 / 40卷 / SUPPL期
关键词：
D O I：
暂无
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
引用
收藏
页码：E84 / E84
页数：1
相关论文
共 50 条
  • [1] PROGNOSTIC VALUE OF MID-REGIONAL PROADRENOMEDULLIN (MR-PROADM) IN PATIENTS WITH CHRONIC KIDNEY DISEASE AND HYPERTENSION
    Czajkowska, Katarzyna
    Zbroch, Edyta
    Bielach-Bazyluk, Angelika
    Koc-Zorawska, Ewa
    Kakareko, Katarzyna
    Rydzewska-Rosolowska, Alicja
    Hryszko, Tomasz
    JOURNAL OF HYPERTENSION, 2021, 39 : E113 - E113
  • [2] Mid-Regional Proadrenomedullin (MR-proADM) and Microcirculation in Monitoring Organ Dysfunction of Critical Care Patients With Infection: A Prospective Observational Pilot Study
    Domizi, Roberta
    Damiani, Elisa
    Scorcella, Claudia
    Carsetti, Andrea
    Giaccaglia, Paolo
    Casarotta, Erika
    Montomoli, Jonathan
    Gabbanelli, Vincenzo
    Brugia, Marina
    Moretti, Marco
    Adrario, Erica
    Donati, Abele
    FRONTIERS IN MEDICINE, 2021, 8
  • [3] Mid-Regional Pro-Adrenomedullin (MR-proADM) as a Biomarker for Sepsis and Septic Shock: Narrative Review
    Onal, Ugur
    Valenzuela-Sanchez, Francisco
    Vandana, Kalwaje Eshwara
    Rello, Jordi
    HEALTHCARE, 2018, 6 (03)
  • [4] Mid-Regional proadrenomedullin (MR-PROADM) may be a new marker of severity status of patient with systemic inflammatory response-pilot project
    Brodska, H. Lahoda
    Svobodova, E.
    Francova, I.
    Tomsovic, M.
    Zima, T.
    CLINICA CHIMICA ACTA, 2024, 558 : 25 - 25
  • [5] The kinetic profiles of copeptin and mid regional proadrenomedullin (MR-proADM) in pediatric lower respiratory tract infections
    Baumann, Philipp
    Fuchs, Aline
    Gotta, Verena
    Ritz, Nicole
    Baer, Gurli
    Bonhoeffer, Jessica M.
    Buettcher, Michael
    Heininger, Ulrich
    Szinnai, Gabor
    Bonhoeffer, Jan
    PLOS ONE, 2022, 17 (03):
  • [6] Mid-regional proadrenomedullin (MR-proADM), C-reactive protein (CRP) and other biomarkers in the early identification of disease progression in patients with COVID-19 in the acute NHS setting
    Moore, Nathan
    Williams, Rebecca
    Mori, Matilde
    Bertolusso, Beatrice
    Vernet, Gabrielle
    Lynch, Jessica
    Philipson, Pete
    Ledgerwood, Thomas
    Kidd, Stephen P.
    Thomas, Claire
    Garcia-Arias, Veronica
    Young, Michelle
    Saeed, Kordo
    Gordon, Kirsty
    Cortes, Nicholas
    JOURNAL OF CLINICAL PATHOLOGY, 2023, 76 (06) : 400 - 406
  • [7] Mid-Regional Proadrenomedullin as a New Biomarker of Kidney and Cardiovascular Diseases-Is It the Future?
    Czajkowska, Katarzyna
    Zbroch, Edyta
    Bielach-Bazyluk, Angelika
    Mitrosz, Katarzyna
    Bujno, Elzbieta
    Kakareko, Katarzyna
    Rydzewska-Rosolowska, Alicja
    Hryszko, Tomasz
    JOURNAL OF CLINICAL MEDICINE, 2021, 10 (03) : 1 - 14
  • [8] Mid-regional pro-adrenomedullin (MR-proADM), a marker of positive fluid balance in critically ill patients: results of the ENVOL study
    Vigue, Bernard
    Leblanc, Pierre-Etienne
    Moati, Frederique
    Pussard, Eric
    Foufa, Hussam
    Rodrigues, Aurore
    Figueiredo, Samy
    Harrois, Anatole
    Mazoit, Jean-Xavier
    Rafi, Homa
    Duranteau, Jacques
    CRITICAL CARE, 2016, 20
  • [9] Mid-regional pro-adrenomedullin (MR-proADM), a marker of positive fluid balance in critically ill patients: results of the ENVOL study
    Bernard Vigué
    Pierre-Etienne Leblanc
    Frédérique Moati
    Eric Pussard
    Hussam Foufa
    Aurore Rodrigues
    Samy Figueiredo
    Anatole Harrois
    Jean-Xavier Mazoit
    Homa Rafi
    Jacques Duranteau
    Critical Care, 20
  • [10] Effectiveness of mid-regional pro-adrenomedullin (MR-proADM) as prognostic marker in COVID-19 critically ill patients: An observational prospective study
    Montrucchio, Giorgia
    Sales, Gabriele
    Rumbolo, Francesca
    Palmesino, Filippo
    Fanelli, Vito
    Urbino, Rosario
    Filippini, Claudia
    Mengozzi, Giulio
    Brazzi, Luca
    PLOS ONE, 2021, 16 (02):
12345